E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/8/2015 in the Prospect News Bank Loan Daily, Prospect News Convertibles Daily and Prospect News Investment Grade Daily.

S&P downgrades St. Jude

Standard & Poor’s said it lowered the ratings on St. Jude Medical Inc., including the corporate credit rating and all issue-level ratings, to A- from A.

The agency also said it removed the ratings from CreditWatch, where they were placed with negative implications in July.

The outlook is negative.

S&P said it lowered the short-term and commercial-paper ratings to A-2 from A-1.

The increase in scale and product offerings from the acquisition of Thoratec will modestly strengthen St. Jude’s competitive position, the agency said.

But the incremental strengthening is more than offset by a considerable increase in debt leverage, the agency said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.